TREATMENT OF INFECTIONS IN MAN WITH CEPHALOTHIN.
D000293:Adolescent; D000900:Anti-Bacterial Agents; D035843:Biomedical Research; D002512:Cephalothin; D002648:Child; D003016:Clostridium perfringens; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D021902:Enterobacter aerogenes; D013293:Enterococcus faecalis; D004927:Escherichia coli Infections; D005853:Geriatrics; D006190:Haemophilus; D007223:Infant; D007231:Infant, Newborn; D008581:Meningitis; D008583:Meningitis, Haemophilus; D011512:Proteus Infections; D013203:Staphylococcal Infections; D013290:Streptococcal Infections; D013296:Streptococcus pneumoniae; D013297:Streptococcus pyogenes; D014376:Tuberculosis; D014391:Tuberculosis, Miliary; D014615:Vaccinia
D000900:Anti-Bacterial Agents; D002512:Cephalothin
ADOLESCENCE; AEROBACTER AEROGENES; ANTIBIOTICS; CEPHALOTHIN; CHILD; CLINICAL RESEARCH; CLOSTRIDIUM PERFRINGENS; DIPLOCOCCUS PNEUMONIAE; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI INFECTIONS; GERIATRICS; INFANT; INFANT, NEWBORN; MENINGITIS, HAEMOPHILUS; PROTEUS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS FAECALIS; STREPTOCOCCUS PYOGENES; TUBERCULOSIS, MILIARY; VACCINIA